Cite
HARVARD Citation
D'Agostino, M. et al. (2018). Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. Critical reviews in oncology/hematology. pp. 9-16. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
D'Agostino, M. et al. (2018). Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. Critical reviews in oncology/hematology. pp. 9-16. [Online].